FDA and FTC Issue Warnings to Companies Selling Fraudulent COVID-19 Treatments
The U.S. Food and Drug Administration and the Federal Trade Commission have sent warning letters to two companies for selling “fraudulent” COVID-19 products. In the FDA’s Tuesday announcement the agency reiterated that there are currently no approved products that prevent or treat COVID-19.
According to the FDA, Honey Colony and Dr. Dhole’s Sushanti Homeopathy Clinic are falsely marketing multiple products as “safe and/or effective for the prevention and treatment of COVID-19.”
Products of concern include, but are not limited to “Jigsaw Magnesium With SRT” and “Quicksilver Liposomal Vitamin C w/Liposomal” from Honey Colony and “Homeopathic Genus Epidemicus” from Dr. Dhole’s.
The FDA advises those concerned about COVID-19 to consult with their health care provider.
Johnson & Johnson Settles West Virginia Pelvic Mesh Lawsuit For $3.9 Million
On Monday, West Virginia Attorney General Patrick Morrisey announced a $3.9 million settlement with Johnson & Johnson over the company’s alleged misleading marketing of pelvic mesh to West Virginia women, according to AP News. The lawsuit, which Morrisey filed in September, claimed that Johnson & Johnson and its subsidiaries misrepresented the risks and effectiveness of their pelvic mesh (also known as transvaginal mesh), at times relying on studies written by paid consultants.
A spokeswoman for Johnson & Johnson subsidiary Ethicon told AP that the settlement did not involve an admission of liability or misconduct.
"This settlement demonstrates our office's commitment to hold accountable corporations who ignore potential risks and side effects or omit such crucial details from the materials provided to doctors and patients,” Morrisey told reporters.
The settlement also resolved allegations that Johnson & Johnson used deceptive marketing practices to promote its metal-on-metal hip replacements.